Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$210,146
-$2,180,215 QoQ
Shares Held
11,705
-39.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,892
of 2,266 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Coppell Advisory Solutions LLC holds $394,497 across 3 Drug Manufacturers - General names. GILD ranks #1 (53.3% of the industry book) .
All Filings in GILD
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $210,146 | 11,705 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $2,390,361 | 19,475 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,224,773 | 20,043 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,233,365 | 20,144 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,613,342 | 23,323 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $3,236,829 | 35,042 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,152,216 | 37,598 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,605,190 | 37,971 | Shares | Sole | 2024-08-15 | |
| 2023-12-31 | $2,198,773 | 27,142 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,355,889 | 18,093 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,719,508 | 22,311 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $1,587,547 | 19,134 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $1,553,284 | 18,093 | Shares | Sole | 2023-05-19 | |
| 2020-12-31 | $547,760 | 9,402 | Shares | Sole | 2021-03-10 | |
| No filing history on record for this holder in this stock. | ||||||